ConductScience.org, home

Trial · NCT02588664

Comprehensive Post-Acute Stroke Services

NCT02588664, Not applicable, Completed, Wake Forest University Health Sciences; results first posted 2021-06-11

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Comprehensive Post-Acute Stroke Services. Trials, record NCT02588664. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02588664

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comprehensive Post-Acute Stroke Services
NCT number
NCT02588664
Status
Completed
Phases
Not applicable
Enrollment
6,024 participants, actual
Lead sponsor
Wake Forest University Health Sciences
Conditions
Stroke, Transient Ischemic Attack
Interventions
COMPASS Intervention
First posted
2015-10-28
Last updated
2021-06-11
Results first posted
2021-06-11
Limitations and caveats
Only 58% of intervention hospitals staffed TC clinics continuously. Patient-level barriers were also present and included preference to see primary care providers, affordability, and transportation. Only 35% of patients enrolled through Intervention hospitals received the COMPASS TC Intervention.

Source ClinicalTrials.gov

Registered outcomes27

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryStroke Impact Scale (SIS-16)post-stroke day 9016-item survey to assess the difficulty level of performing basic physical activities; scores range from 0-100; higher scores correspond to more favorable outcomes
SecondaryModified Caregiver Strain Indexpost-stroke day 9013-item survey to measure strain that caregivers may experience; scores range from 0-100; higher scores indicate more caregiver burden
SecondarySelf-reported General Healthpost-stroke day 90
Self-reported general health is a single question to rate their general health. Responses on a 5-point Likert Scale (Excellent, Very Good, Good, Fair, or Poor) will be analyzed as a continuous variable. Scores range from 95-15 with a higher score indicating better health.
SecondaryModified Rankin Scorepost-stroke day 90to measure the degree of disability or dependence; scores range from 0-6; higher scores correspond to less favorable outcomes
SecondaryNumber of Participants Physically Active and Not Physically Activepost-stroke day 90
Participants are asked whether they walked continuously for at least 10 minutes on any of the last seven days, how many of those days they walked continuously for at least 10 minutes and how many minutes they walked, on average, each day. The physical activity endpoint will be self-reported total number of minutes walked during the past seven days.
SecondaryNumber of Participants With or Without Depressionpost-stroke day 90
Based on answers to Patient Health Questionnaire 2-Item (PHQ-2) which is a 2-item questionnaire to determine the frequency of depressed mood; scores range from 0-6; higher scores correspond to less favorable outcomes
SecondaryCognition (MoCA 5-min Protocol)post-stroke day 904-item questionnaire to determine vascular cognitive impairment; scores range from 0-30; higher scores are more favorable
SecondaryMedication Adherence (Morisky Green Levine Scale-4)post-stroke day 904 items with yes/no response options; scores range from 0-4; higher scores correspond to less medication adherence
SecondaryNumber of Participants With or Without Fallspost-stroke day 90
Participants are asked 4 questions to determine whether they have fallen (yes versus no) since hospital discharge, whether or not the fall resulted in a doctor/emergency room visit, whether they have fallen multiple times since discharge, and how many times they have fallen since discharge. Analysis of falls will be based on incidence of any fall since hospital discharge (no falls versus at least one fall).
SecondarySelf-reported Fatigue (PROMIS Fatigue Instrument)post-stroke day 90
4-question instrument to determine level of fatigue; higher scores correspond to less favorable outcomes; The total raw score is obtained by summing individual question scores and has a range of 4-20. For analysis, raw scores are translated into T-scores which range from 33.7 - 75.8. The T-score rescales the raw score into a standardized score with a mean of 50 and a SD of 10.

Outcomes27

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYStroke Impact Scale (SIS-16)post-stroke day 90
Of the 5,882 that were enrolled in the study, 3476 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure
score on a scaleMEAN
SECONDARYModified Caregiver Strain Indexpost-stroke day 90
Each enrolled patient was asked to identify a caregiver. A total of 4208 caregivers were identified and asked to complete the Caregiver Questionnaire. A total of 1228 caregivers completed the Caregiver Survey. However, to account for missing data, we utilized inverse probability weight to perform the analysis so the final analysis included was 4208 for this outcome.
score on a scaleMEAN
SECONDARYSelf-reported General Healthpost-stroke day 90
Of the 5,882 that were enrolled in the study, 3169 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
score on a scaleMEAN
SECONDARYModified Rankin Scorepost-stroke day 90
Of the 5,882 that were enrolled in the study, 3209 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
score on a scaleMEDIAN
SECONDARYNumber of Participants Physically Active and Not Physically Activepost-stroke day 90
Of the 5,882 that were enrolled in the study, 2968 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With or Without Depressionpost-stroke day 90
Of the 5,882 that were enrolled in the study, 2,774 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCognition (MoCA 5-min Protocol)post-stroke day 90
Of the 5,882 that were enrolled in the study, 2,728 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
score on a scaleMEAN
SECONDARYMedication Adherence (Morisky Green Levine Scale-4)post-stroke day 90
Of the 5,882 that were enrolled in the study, 2,730 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
score on a scaleMEDIAN
SECONDARYNumber of Participants With or Without Fallspost-stroke day 90
Of the 5,882 that were enrolled in the study, 3,055 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSelf-reported Fatigue (PROMIS Fatigue Instrument)post-stroke day 90
Of the 5,882 that were enrolled in the study, 2,721 provided a response to the survey question. However, we utilized inverse probability weight to perform the analysis in a way to account for missing data. The final analysis included 5,882 for this outcome measure.
score on a scaleMEAN

Results by group52

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Stroke Impact Scale (SIS-16)Usual Care79.9Standard Deviation 21.4score on a scale
Stroke Impact Scale (SIS-16)COMPASS Intervention80.6Standard Deviation 21.1score on a scale
Modified Caregiver Strain IndexUsual Care21.9Standard Deviation 23.1score on a scale
Modified Caregiver Strain IndexCOMPASS Intervention21.9Standard Deviation 23.5score on a scale
Self-reported General HealthUsual Care65.4Standard Deviation 28.8score on a scale
Self-reported General HealthCOMPASS Intervention66.2Standard Deviation 28.8score on a scale
Modified Rankin ScoreUsual Care1Inter-Quartile Range 0 to 3score on a scale
Modified Rankin ScoreCOMPASS Intervention1Inter-Quartile Range 0 to 3score on a scale
Number of Participants Physically Active and Not Physically ActiveUsual CareYes Physically Active (150 min/week of physical activity or more)488Participants
Number of Participants Physically Active and Not Physically ActiveCOMPASS InterventionYes Physically Active (150 min/week of physical activity or more)431Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDUsual Care3,193
Overall StudySTARTEDCOMPASS Intervention2,689
Overall StudyCOMPLETEDUsual Care1,832
Overall StudyCOMPLETEDCOMPASS Intervention1,644
Overall StudyNOT COMPLETEDUsual Care1,361
Overall StudyNOT COMPLETEDCOMPASS Intervention1,045

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityUsual Care563,193
Total, all-cause mortalityCOMPASS Intervention552,689
Total, other adverse eventsUsual Care00
Total, other adverse eventsCOMPASS Intervention00
Total, serious adverse eventsUsual Care03,137
Total, serious adverse eventsCOMPASS Intervention02,689

Papers23

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
27125528BACKGROUNDPubMed
28649454BACKGROUNDPubMed
28716014BACKGROUNDPubMed
29373987BACKGROUNDPubMed
29572814BACKGROUNDPubMed
29720489BACKGROUNDPubMed
30354371BACKGROUNDPubMed
30635495BACKGROUNDPubMed
31856808RESULTPubMed
32275060BACKGROUNDPubMed

1 to 10 of 23

See all 23 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons8

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based All-cause Hospital ReadmissionsTrial comparisons
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based All-cause Hospital ReadmissionsTrial comparisons
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based Admissions to Skilled Nursing Facilities (SNF) and Inpatient Rehabilitation Facilities (IRF)Trial comparisons
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based Emergency Department VisitsTrial comparisons
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based Use of Transitional Care Management Billing CodesTrial comparisons
COMPASS Intervention vs Usual Care: deaths from any causeTrial comparisons
COMPASS Intervention vs Usual Care: Number of Subjects With Claims-based All-cause Hospital ReadmissionsTrial comparisons
COMPASS Intervention vs Usual Care: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02588664

GET https://conductscience.org/api/trials/v1/NCT02588664/registered?page=2